Meeting
2019 ASCO Annual Meeting
Voltage: Investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer.
Authors
Takayuki Yoshino
National Cancer Center Hospital East, Kashiwa, Japan
Takayuki Yoshino , Hideaki Bando , Yuichiro Tsukada , Koji Inamori , Satoshi Yuki , Yoshito Komatsu , Shigenori Homma , Mamoru Uemura , Takeshi Kato , Daisuke Kotani , Shota Fukuoka , Takeshi Sasaki , Yuji Nishizawa , Naoki Nakamura , Masashi Wakabayashi , Motohiro Kojima , Yosuke Togashi , Akihiro Sato , Hiroyoshi Nishikawa , Masaaki Ito
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
NCT02948348
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3606)
DOI
10.1200/JCO.2019.37.15_suppl.3606
Abstract #
3606
Poster Bd #
98
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
First Author: Satoshi Yuki
Poster
2021 Gastrointestinal Cancers Symposium
Translational research of VOLTAGE-A: Efficacy predictors of preoperative chemoradiotherapy and consolidation nivolumab in patients with both microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
First Author: Koji Inamori
Poster
2018 Gastrointestinal Cancers Symposium
VOLTAGE: Multicenter phase 1b/II study of nivolumab monotherapy and subsequent radical surgery after preoperative chemoradiotherapy with capecitabine in patients with locally advanced rectal cancer.
First Author: Yuichiro Tsukada
Poster
2023 ASCO Annual Meeting
Predictive value of tumor-infiltrating lymphocyte (TIL) dynamics in the tumor microenvironment (TME) during preoperative chemoradiotherapy (CRT) on pathologic complete response (pCR) in microsatellite-stable (MSS) locally advanced rectal cancer (LARC).
First Author: Mitsuho Imai